Literature DB >> 8448902

Attitudes of Dutch general practitioners towards presymptomatic DNA-testing for Huntington disease.

R Thomassen1, A Tibben, M F Niermeijer, E van der Does, J J van de Kamp, F Verhage.   

Abstract

The attitudes of 1020 Dutch GP's towards presymptomatic and prenatal testing for Huntington disease (HD) were studied by means of a postal questionnaire. The questionnaire contained questions about: approval of presymptomatic DNA-testing, informing individuals at-risk who do not request predictive testing, referral to a clinical genetics center, and opinions about different strategies of informing and supporting individuals at-risk. The response rate was 62%. More than two-thirds of the GP's considered post-test counselling and support as their responsibility. Twenty-six per cent were of the opinion that the test results should be disclosed by the GP. Fifty-nine per cent of GP's who had an individual at-risk in their practice were familiar with the test. The attitudes of GP's towards giving support and giving test results were independent of familiarity with the test and the incidence of HD-patients or at-risk individuals in the practice. Although GP's were willing to play an important role in presymptomatic DNA-testing procedures, there is a risk that they might underestimate the difficulties in communicating genetic information and the psychosocial effects of DNA-testing. Hence, we favor the premise that extensive pretest counselling and test disclosure should remain the prime responsibility of the clinical geneticist. Increasing involvement of GP's should, however, be encouraged and combined with appropriate postgraduate education about predictive DNA-testing in general.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Year:  1993        PMID: 8448902     DOI: 10.1111/j.1399-0004.1993.tb04428.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  3 in total

1.  Preparing for presymptomatic DNA testing for early onset Alzheimer's disease/cerebral haemorrhage and hereditary Pick disease.

Authors:  A Tibben; M Stevens; G M de Wert; M F Niermeijer; C M van Duijn; J C van Swieten
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

2.  Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany.

Authors:  U Thies; B Bockel; V Bochdalofsky
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

3.  Decision-making about reproductive choices among individuals at-risk for Huntington's disease.

Authors:  Robert Klitzman; Deborah Thorne; Jennifer Williamson; Wendy Chung; Karen Marder
Journal:  J Genet Couns       Date:  2007-06       Impact factor: 2.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.